Smart eye drop cap to help with glaucoma drop routines
Part of Eyes & vision clinical trials.
This trial tests whether a special cap called iD2 helps people remember to take their glaucoma eye drops on time. If you've struggled to keep up with your eye drops, this may help you build a better routine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must use at least one glaucoma eye drop every day.
- You must feel you have missed 20% or more of your eye drops in the past month.
- You must own a smartphone that connects to Bluetooth and cellular data.
- You must not have significant memory or thinking problems.
- You cannot be pregnant or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
This study tests tools to help you use your glaucoma eye drops correctly. If you've been using the same drops for at least two months, you may be able to join.
This study tests a smart contact lens that may help monitor glaucoma by measuring eye pressure. It is looking for people with glaucoma (who already use eye-drop medicine) and healthy adults without glaucoma to see if the lens works well over time.
This study tests whether measuring your eye pressure at home with a special device can help control glaucoma and slow its progression. It may offer a more convenient way to track your condition between doctor visits.
This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.